Source:http://linkedlifedata.com/resource/pubmed/id/15371635
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2004-9-16
|
pubmed:abstractText |
HIV-protease inhibitor (HIV-PI) drugs are critical for highly active antiretroviral therapy (HAART) efficacy, but several recent reports have suggested that metabolic and/or cardiovascular toxicities are associated with these drugs. Given the importance of the HIV-PI drug class and the widespread and chronic use of these agents in an expanding patient population, further understanding of this potential drug toxicity is imperative. Here, we investigated a role for direct endothelial toxicity induced by saquinavir (SAQ), the first HIV-PI drug marketed in the United States and still an important component of HAART therapies. In initial studies using isolated vascular tissues, we observed selective impairment of endothelium-dependent vasodilation with no effect on contractile responses. Subsequent studies using human endothelial cells in culture at clinically relevant concentrations (5 and 10 microM, 2-48 h) demonstrated concentration-dependent increases in cell death, mainly via apoptosis rather than necrosis (determined via Annexin-V positive membrane labeling). Live cell imaging also demonstrated increased intracellular oxidant production (as measured by DCF fluorescence), which could be abrogated by incubation with the antioxidant N-acetylcysteine (NAC). NAC also prevented SAQ- induced apoptotic cell death. These data demonstrate that SAQ has direct toxicological effects on endothelial cells, and that the toxicity apparently involves apoptotic pathway activation via reactive oxygen and/or nitrogen species.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1530-7905
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
199-206
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15371635-Animals,
pubmed-meshheading:15371635-Aorta, Thoracic,
pubmed-meshheading:15371635-Apoptosis,
pubmed-meshheading:15371635-Cell Line,
pubmed-meshheading:15371635-Cell Survival,
pubmed-meshheading:15371635-Endothelial Cells,
pubmed-meshheading:15371635-Endothelium, Vascular,
pubmed-meshheading:15371635-HIV Protease Inhibitors,
pubmed-meshheading:15371635-Humans,
pubmed-meshheading:15371635-Male,
pubmed-meshheading:15371635-Necrosis,
pubmed-meshheading:15371635-Rats,
pubmed-meshheading:15371635-Rats, Sprague-Dawley,
pubmed-meshheading:15371635-Reactive Oxygen Species,
pubmed-meshheading:15371635-Saquinavir,
pubmed-meshheading:15371635-Umbilical Veins,
pubmed-meshheading:15371635-Vasodilation
|
pubmed:year |
2004
|
pubmed:articleTitle |
Vascular endothelial toxicity induced by HIV protease inhibitor: evidence of oxidant-related dysfunction and apoptosis.
|
pubmed:affiliation |
Department of Pharmacology, College of Pharmacy, Ohio State University, Columbus, OH 43205, USA.
|
pubmed:publicationType |
Journal Article,
In Vitro
|